A look ahead at this week in women's health from Contemporary OB/GYN:
At ACR Convergence 2022, Hyun Son, PharmD, discussed the role of the FDA’s Drug Shortage Staff in preventing and mitigating drug shortages.
Cleveland Clinic begins charging for doctors’ time spent responding to some electronic messages
At ACR Convergence 2022, Amit Golding, MD, PhD, outlined drugs recently approved by the FDA, and discussed the requirements for biosimilars to meet approval.
Exposure to more than 100 mg was linked to significantly lower odds ratios for first-ever ACS event for women.
The association between type of body composition and fibromyalgia was evaluated using 43 women with clinically diagnosed fibromyalgia.
Check back soon for additional updates.
A legacy of excellence: Reflecting on the final print edition of Contemporary OB/GYN
April 25th 2025Marking the end of an era and the beginning of a new chapter, the final print edition of Contemporary OB/GYN celebrates over 50 years of evidence-based guidance and unwavering support for clinicians.
Read More